1. 746PCOnsensus statement on mandatory measurements in PAncreatic cancer trials for systemic treatment of unresectable disease (COMM-PACT). (18th September 2017) Authors: van Rijssen, L.B.; ter Veer, E.; Besselink, M.G.; Mali, R.M.A.; Berlin, J.; Boeck, S.; Bonnetain, F.; Conroy, T.; Deplanque, G.; Goldstein, D.; Glimelius, B.; Neoptolemos, J.P.; Reni, M.; Scheithauer, W.; van der Meer, J.; Wilmink, J.W.; van der Poel, M.J.; Busch, O.R.; van Oijen, M.G.H.; van Laa... Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2089 Response to chemotherapy allows to identify mCRC patients most likely to benefit from maintenance immunotherapy: A post-hoc analysis from the IMPACT study. (September 2015) Authors: Scheithauer, W.; Riera-Knorrenschild, J.; Kopp, H.G.; Mayer, F.; Kroening, H.; Nitsche, D.; Kuhlmann, J.; Ziebermayr, R.; Andel, J.; Arnold, D.; Zurlo, A.; Wittig, B.; Schmoll, H.J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 447 Extended Analysis for Cancer Treatment (EXACT): Interim analysis of a prospective precision medicine trial. (September 2015) Authors: Prager, G.; Unseld, M.; Waneck, F.; Raderer, M.; Krainer, M.; Fuereder, T.; Hejna, M.; Staber, P.; Scheithauer, W.; Schmidinger, M.; Thallinger, C.; Farkas, L.; Reinthaller, A.; Polterauer, S.; Wrba, F.; Muellauer, L.; Mader, R.; Zielinski, C.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). (January 2019) Authors: Holch, J.W.; Ricard, I.; Stintzing, S.; Fischer von Weikersthal, L.; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Heintges, T.; Kahl, C.; Kullmann, F.; Scheithauer, W.; Moehler, M.; Jelas, I.; Modest, D.P.; Westphalen, C.B.; von Einem, J.C.; Michl, M.; Heinemann, V. Journal: European journal of cancer Issue: Volume 106(2019) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306). (October 2017) Authors: Modest, D.P.; Ricard, I.; Stintzing, S.; Fischer von Weikersthal, L.; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Al-Batran, S.-E.; Heintges, T.; Kahl, C.; Seipelt, G.; Kullmann, F.; Scheithauer, W.; Moehler, M.; Westphalen, C.B.; Holch, J.W.; von Einem, J.C.; Held, S.; Heinemann, V. Journal: European journal of cancer Issue: Volume 84(2017) Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MONDTI: Molecular characterisation platform for identifying actionable mutations in advanced or metastatic cancers. (December 2016) Authors: Kieler, M.; Warzecha, A.; Müllauer, L.; Waneck, F.; Mader, R.; Wrba, F.; Schmidinger, M.; Scheithauer, W.; Marosi, C.; Raderer, M.; Hejna, M.; Füreder, T.; Staber, P.; Preusser, M.; Jäger, U.; Reinthaller, A.; Berger, W.; Bartsch, R.; Zielinski, C.; Prager, G. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗